| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $600.2M | $574.7M | $546.3M |
| YoY Revenue Growth % | +4.4% | +5.2% | — |
| Gross Profit | $344.1M | $327.5M | — |
| Gross Margin % | 57.3% | 57.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$18.0M | -$10.3M | -$83.4M |
| Operating Margin % | -3.0% | -1.8% | -15.3% |
| Net Income (GAAP) | -$31.4M | -$26.0M | -$98.9M |
| EBITDA (Normalized) | -$4.4M | -$1.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $16.4M | $669.0K | $33.4M |
| Capital Expenditures (CapEx) | $17.1M | $11.6M | — |
| Free Cash Flow (FCF) | -$633.0K | -$10.9M | $33.4M |
| FCF Margin % | -0.1% | -1.9% | 6.1% |
| Return on Invested Capital (ROIC %) | -7.8% | -4.1% | — |
| Cash & Short-Term Equivalents | $20.3M | $24.2M | — |
| Total Debt (Short + Long Term) | $104.7M | $105.4M | — |
| Total Stockholders' Equity | $97.8M | $117.6M | — |